Dr. Patrick T. Quaid (Optometrist, MCOptom, FCOVD, PhD) is a practitioner, researcher, author and lecturer on vision development. Dr. Quaid mainly deals with treatment visual dysfunction both in concussion-related cases and learning difficulty related cases.
He is an Adjunct Professor (University of Waterloo School of Optometry & Vision Science, Ontario, Canada) and CEO of VUE-Cubed Vision Therapy (www.vuetherapy.ca) in addition to currently serving on the board of directors for COVD International (College of Optometrists in Vision Development, www.covd.org, USA based not-for-profit group).
Originally from the Republic of Ireland, Dr. Quaid originally studied Statistical Mathematics and subsequently trained as an Optometrist in the UK (University of Bradford School of Optometry) and subsequently worked in the UK Hospital Eyecare System (Moorfield’s Eye Hospital, London & Bradford Royal Infirmary, West Yorkshire) specifically dealing with the pre-operative and post-operative treatment of strabismus and co-management of glaucoma.
Dr. Quaid was awarded his Doctorate in Vision Science at the University of Waterloo School of Optometry & Vision Science in 2005 in addition to completing a Post-Doctorate funded by the Canadian Institute of Health Research (CIHR). Dr. Quaid’s Ph.D. thesis and post-doctoral research aided in the development of an early detection device for glaucoma (Heidelberg Edge Perimeter) which is in commercial use. Dr. Quaid serves as Adjunct Faculty at both the University of Waterloo School of Optometry and also consults with the David L. MacIntosh Sports Medicine Clinic (Toronto). He has published several papers as the first author in high impact optometry and ophthalmology journals such as Investigative Ophthalmology and Vision Science and Graefe’s Archives of Clinical & Experimental Ophthalmology on topics related to both glaucoma and the challenging area of binocular vision dysfunction and it relates to learning disabilities and concussion based injuries.
“Dr. Quaid has delivered over 550 lectures to educators, doctors, injury lawyers, physiotherapists and sports medicine specialists dealing with concussion injuries both in North America and internationally. He has delivered invited lectures at Ohio State University, University of Berkeley California, McMaster Medical School and also the University Healthcare Network (UHN) in Ontario in addition to having given interviews to media outlets including the Canadian Broadcasting Corporation (CBC). Dr. Quaid has also bee interviewed by concussion podcast leader Ben Fanelli (“Heroic Minds podcasts”) on topics pertaining to eye teaming disorders in both reading based learning difficulties and concussion injuries”.
In addition to his PhD and Post-Doctorate training in Vision Science, Dr. Quaid has also completed his Fellowship Training with the College of Optometrists in Vision Development (www.covd.org) in the area of Optometric Vision Therapy and Rehabilitation, which represents USA Board Certification level training. Dr. Quaid also currently serves as the Vice-President of his regulatory board (Ontario College of Optometrists) as well as Chair of the Registration Committee.
In addition to having received the University of Waterloo Presidents Award for Excellent in Research during his doctorate years, Dr. Quaid also received an award pertaining to his research in 2019 from the Neuro-Optometric Rehabilitation Association (NORA) in the USA for his publications pertaining to traumatic brain injury and its effects on the visual system (along with Dr. Eric Singman MD PhD, Head of Neuro-Ophthalmology at Johns Hopkins in Baltimore, MD). In Jan 2019, Dr. Quaid along with Dr. Singman, co-authored a landmark medical book chapter on the effects of concussion on visual function (Book Title: “Neurosensory Disorders in Mild Traumatic Brain Injury”) which has quickly become an expert opinion piece in injury case law in North America.
In 2014, Dr. Quaid opened his first clinic dedicated solely to Optometric Vision Therapy & Rehabilitation in Guelph and has since expended to two clinics (second location in Toronto, see www.vuetherapy.ca). These VUE3 clinics are the first of their kind to integrate research and a clinic solely dedicated to vision therapy, which has successfully been granted research funding from the Canadian Government (SR&ED funding). This model, which is unheard of in a private clinic setting, has managed to integrate groundbreaking clinical treatments with clinical translational research in order to add to the literature by harnessing data on real patient cases in real time. This is the realm in which Dr. Quaid thrives – an environment that helps people to get their lives back and thrive but also marries this important missing statement with the requirement for data and a rigorous research methodology. VUE3 represents the perfect combination of true clinical translational research and excellence in clinic care.